Home › Core › ISCC-IDs › 28C6MitrcVT4Y

View ISCC-ID

Core Data

28C6MitrcVT4Y
ISCC-ID - digital asset identifier
CCNzQDzRGC26x-CTKx4HwPc9iVg-CDMCpKXSDEkUE-CR4RoWumfhxji
ISCC-CODE - digital asset descriptor
2QTa5N4aeSrCB2MLoPdPF4AsTjstJgcLTnd
PUBLIC-KEY or WALLET-ADDRESS of DECLARING PARTY
0
Number of times updated

Seed Metadata (Immutable)

retraction cheng bq et al chemoembolization combined with radiofrequency ablation for patients with hepatocellular carcinoma lar

Ledger Reference

coblo
Source Ledger/Blockchain
12403264
N-th ISCC Decleration on source ledger
7e3bb99467ddc1c6310870b2d686d8bcb3b8a83a520abcebbb2228140f96e49a
Hash of block that includes the ISCC-DECLARATION
9c40059ebda1def755abe9e82c3b249ad7b7ac27f230fe7f19055ec23a6449cc
Hash of transaction that includes the ISCC-DECLERATION
0
Output index that includes ISCC-DECLERATION (UTXO based chains)

Mutable Metadata

[{"data": {"name": "Retraction: Cheng B-Q, et al. Chemoembolization combined with radiofrequency ablation for patients with hepatocellular carcinoma larger than 3 cm: a randomized controlled trial. <emph type=\"ital\">JAMA</emph>. 2008;299(14):1669-1677.", "@type": "ScholarlyArticle", "genre": "journal-article", "author": [{"name": "Catherine D. DeAngelis", "@type": "Person"}], "@context": "http://schema.org/", "encoding": [{"@type": "MediaObject", "contentUrl": "https://jamanetwork.com/journals/jama/articlepdf/183872/jed90017_1931_1931.pdf", "encodingFormat": "application/pdf"}], "publisher": {"name": "American Medical Association (AMA)", "@type": "Organization"}, "identifier": [{"@type": "PropertyValue", "value": "10.1001/jama.2009.640", "propertyID": "DOI"}, {"@type": "PropertyValue", "value": "CCNzQDzRGC26x-CTKx4HwPc9iVg-CDMCpKXSDEkUE-CR4RoWumfhxji", "propertyID": "ISCC"}], "datePublished": "2009-05-13"}, "schema": "schema.org", "mediatype": "application/ld+json"}]
Close